You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Details for Patent: 10,442,847

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 10,442,847 protect, and when does it expire?

Patent 10,442,847 protects ZEGALOGUE and ZEGALOGUE (AUTOINJECTOR) and is included in one NDA.

This patent has thirty-three patent family members in twenty-four countries.

Summary for Patent: 10,442,847

Title:	Glucagon analogues
Abstract:	The present invention relates to glucagon analogs and their medical use, for example in the treatment of hypoglycaemia. In particular, the present invention relates to stable glucagon analogs suitable for use in a liquid formulation.
Inventor(s):	Riber; Ditte (Bronshoj, DK), Giehm; Lise (Frederiksberg, DK)
Assignee:	Zealand Pharma A/S (Soborg, DK)
Application Number:	14/417,074
Patent Claim Types: see list of patent claims	Composition; Compound;

Drugs Protected by US Patent 10,442,847

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Zealand Pharma	ZEGALOGUE	dasiglucagon hydrochloride	SOLUTION;SUBCUTANEOUS	214231-001	Mar 22, 2021		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial	Y	Y			⤷ Try a Trial
Zealand Pharma	ZEGALOGUE (AUTOINJECTOR)	dasiglucagon hydrochloride	SOLUTION;SUBCUTANEOUS	214231-002	Mar 22, 2021		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial	Y	Y			⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 10,442,847

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Denmark	PA 2013 00360	Jun 14, 2013

PCT Information
PCT Filed	July 23, 2013	PCT Application Number:	PCT/EP2013/065519
PCT Publication Date:	January 30, 2014	PCT Publication Number:	WO2014/016300

International Family Members for US Patent 10,442,847

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	091866	⤷ Try a Trial
Australia	2013295035	⤷ Try a Trial
Brazil	112015001451	⤷ Try a Trial
Canada	2878991	⤷ Try a Trial
China	104662038	⤷ Try a Trial
China	109456400	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.